Record Currency Management wins new FX Alpha and Frontier Market mandates September 10, 2026 Record Currency Management Ltd (RCM), a subsidiary of London-listed Record plc (Record Financial Group), is pleased to announce that it has been awarded two new mandates of strategic importance – an FX Alpha mandate and an FX Frontier mandate. RCM is the UK currency management arm of Record Financial Group, the London-listed specialist investment group [...]
Agentic Crypto Payments Have Surged by 500%1 in the Last Three Months, Crypto Compliance Must Become Agentic Too September 10, 2026 Elliptic is publishing eight principles for governing agentic on-chain risk: the Elliptic Standard
BGC Group Announces its First-Ever Fully AI Brokered Institutional Trade in Listed Equity Derivatives September 10, 2026 Fully autonomous transaction between two institutional accounts marks milestone in AI-powered trading
OMBA Runs FINBOURNE Agentic AI in Production Across Daily Investment Operations September 10, 2026 OMBA Advisory & Investments and FINBOURNE Technology today announced that OMBA has been running FINBOURNE agents in production for six months across its daily investment operations, reducing its operational burden by at least 20%. The agents provide coverage across a large portion of OMBA’s daily operational cycle from morning data load checks and reconciliations through [...]
New Circularity Data: Nine Out of Ten Returned Items Lose Value for Retailers September 10, 2026 New research finds 86% of retailers have established circularity practices, yet only 9% resell more than half of returned products at full price
Alkermes Announces Launch of 9th Annual Alkermes Pathways Research Awards® Program September 10, 2026 — Competitive Grant Program to Offer Individual Grants of Up to $100,000 per Project — — Areas of Interest Expanded to Include Narcolepsy and Idiopathic Hypersomnia in Addition to Schizophrenia and Bipolar I Disorder — — Stage One Submission Period Runs From Sept. 11, 2026 Through Oct. 16, 2026 —
Ride Therapeutics Announces up to US$7.3 Million Investment from the Cystic Fibrosis Foundation to Advance Next-Generation Genetic Medicines September 10, 2026 Investment will support Ride's Molecular Logistics™ platform with the goal of delivering genetic medicines to the lung for all people living with cystic fibrosis Ride’s platform is designed to learn the rules of delivery by tracking the destinations of millions of diverse carriers for genetic medicines in the body Billions of datapoints can be used to train a generative AI design engine and produce optimized carriers for any tissue or cell type of interest Investment is expected to both accelerate Ride’s existing progress using IV delivery and support expansion of the technology for inhaled delivery Ride was launched in 2023, funded by an US$8.0 million seed round
Transition Bio Partners with the Little Warrior Foundation September 10, 2026 Transition Bio receives $750,000 grant from the Little Warrior Foundation Mission: advance science in one of cancer’s most elusive targets - EWS-FLI1 Goal: create a therapeutic for an aggressive pediatric cancer – Ewing Sarcoma Leverage Transition Bio’s molecular drug discovery + protein science-based approach Enabled by Transition Bio’s proprietary physical science tools, data and machine learning
Trolley Research: Independent Earners Won’t Wait More Than Two Days to Get Paid, and Payment Problems Are Pushing Them Off Platforms September 10, 2026 A survey of 450 freelancers, creators, and musicians finds only 28% control when their money arrives, while payment delays now outrank a lack of work as a reason to leave
GasEntec Announces New Ownership Structure, Accelerating Next Phase of Global Growth September 10, 2026 Independent LNG infrastructure and technology company expands investment in proprietary technology, modular solutions and global project development.